^“In-vitro activity of flomoxef, a new oxacephem group antibiotic, against Nocardia in comparison with other cephalosporins”. J. Antimicrob. Chemother.24 (6): 921–5. (December 1989). doi:10.1093/jac/24.6.921. PMID2621177.
^“Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects”. Int J Clin Pharmacol Ther Toxicol31 (3): 148–52. (March 1993). PMID8468113.